PubMed ID: 36531570 Author(s): Domalpally A, Slater R, Barrett N, Voland R, Balaji R, Heathcote J, Channa R, Blodi B. Implementation of a large-scale image curation workflow using deep learning framework. Ophthalmol Sci. 2022 Jul …
Amitha Domalpally
Retinal Thickness and Morphology Changes on OCT in Youth with Type 2 Diabetes: Findings from the TODAY Study.
PubMed ID: 36531589 Author(s): Mititelu M, Uschner D, Doherty L, Bjornstad P, Domalpally A, Drews KL, Gubitosi-Klug R, Levitsky LL, Pak JW, White NH, Blodi BA. Retinal thickness and morphology changes on OCT in youth …
Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 30.
PubMed ID: 35660417 Author(s): Agrón E, Domalpally A, Cukras CA, Clemons TE, Chen Q, Lu Z, Chew EY, Keenan TDL; AREDS and AREDS2 Research Groups. Reticular pseudodrusen: The third macular risk feature for progression to …
Total retinal thickness: a neglected factor in the evaluation of inner retinal thickness.
PubMed ID: 36329022 Author(s): Banghart M, Lee K, Bahrainian M, Staggers K, Amos C, Liu Y, Domalpally A, Frankfort BJ, Sohn EH, Abramoff M, Channa R. Total retinal thickness: a neglected factor in the evaluation …
Redefining the Spectrum of Pentosan Polysulfate Retinopathy: Multimodal Imaging Findings from a Cross-Sectional Screening Study.
PubMed ID: 35339727 Author(s): Dieu AC, Whittier SA, Domalpally A, Pak JW, Voland RP, Boyd KM, Gottlieb JL, Crabtree GS, Giles DL, McAchran SE, Mititelu M. Redefining the spectrum of pentosan polysulfate retinopathy: Multimodal imaging …
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
PubMed ID: 35653117 Author(s): Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to …
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.
PubMed ID: 35525297 Author(s): Yaghy A, Lee AY, Keane PA, Keenan TDL, Mendonca LSM, Lee CS, Cairns AM, Carroll J, Chen H, Clark J, Cukras CA, de Sisternes L, Domalpally A, Durbin MK, Goetz KE, …
Artificial Intelligence Algorithms in Diabetic Retinopathy Screening.
PubMed ID: 35438458 Author(s): Zafar S, Mahjoub H, Mehta N, Domalpally A, Channa R. Artificial Intelligence Algorithms in Diabetic Retinopathy Screening. Curr Diab Rep. 2022 Jun;22(6):267-274. doi: 10.1007/s11892-022-01467-y. Epub 2022 Apr 19. Review. PMID 35438458 …
Disease-modifying effects of ranibizumab for central retinal vein occlusion.
PubMed ID: 34613454 Author(s): Huang JM, Khurana RN, Ghanekar A, Wang PW, Day BM, Blodi BA, Domalpally A, Quezada-Ruiz C, Ip MS. Disease-modifying effects of ranibizumab for central retinal vein occlusion. Graefes Arch Clin Exp …